PRN: Osteoarthritis - Forecast in 12 Major Markets 2016-2026 - Overview of Risk Factors, Disease Diagnosis & Prognosis - Research and Markets

06/feb/2017 18:10:11 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Osteoarthritis - Forecast in 12 Major Markets 2016-2026 - Overview of Risk Factors, Disease Diagnosis & Prognosis - Research and Markets


DUBLIN, Feb 6, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Osteoarthritis Forecast in 12 Major Markets 2016-2026" report to their offering.

Osteoarthritis (OA), also known as degenerative joint disease / degenerative arthritis, is an inflammation of the articular cartilage and sub-chondral bone. OA is actually a collection of diseases rather than one disease per se: can be primary (chronic degenerative disorder related to but not caused by age, with a strong genetic linkage - reports of - 60%) or secondary (caused by injury, infection / inflammation and as a consequence of other chronic diseases).

This report provides the current prevalent population for Osteoarthritis across 12 Major Markets (USA, France, Germany, Italy, Spain, UK, Russian Federation, Canada, Brazil, Japan, India</! span> and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

There are a number of conditions that co-occur with OA including:

  • Congenital joint abnormalities (Marfan syndrome)
  • Metabolic defects (eg, hemochromatosis, Wilson disease)
  • Infections (causing post infectious arthritis)
  • Endocrine and neuropathic diseases
  • Rheumatoid Arthritis
  • Gout
  • Chondrocalcinosis
  • Obesity

Reasons to Buy:

  • Able to quantify patient populations in global Osteoarthritis market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Osteoarthritis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Osteoarthritis's prevalent population.
  • Identify sub-populations within Osteoarthritis which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Osteoarthritis patients.

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key comorbid conditions/Features associated with the disease

8. Methodology for quantification of patient numbers

9. Top-line prevalence for Osteoarthritis

10. Symptomatic OA patients

11. HIP Osteoarthritis

12. Knee Osteoarthritis

13. Joint replacement in OA

14. Abbreviations used in the report

15. Patient-Based Offering

16. Online Pricing Data and Platforms

17. References

18. Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus è un servizio offerto da Factotum Srl